Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Eli Lilly Whomps Novo Nordisk
Eli Lilly’s Zepbound Beats Novo Nordisk’s Wegovy in First Head-to-Head Study
People who took Zepbound lost 17 pounds more on average after 72 weeks of treatment than those who were given Novo Nordisk’s drug.
Eli Lilly's Zepbound Tops Novo Nordisk's Wegovy in Weight-Loss Trial
Eli Lilly's popular weight-loss drug Zepbound outperformed Danish drugmaker Novo Nordisk's Wegovy in a clinical trial, according results of the study released Wednesday.
Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in a study.
3d
Exclusive: Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular ...
1d
on MSN
Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments
Eli
Lilly
said it would invest $3 billion to expand a recently ... a study that claimed that its Zepbound obesity drug is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Manslaughter dropped
US adds 227,000 jobs
Family awarded $310 million
Taking extended leave
Drops bid for third term
Havana syndrome report
Climbers feared dead
Federal fraud charges arrest
Biden considers pardons
Several prisons to be closed
Trump shows public support
‘One Life to Live’ star dies
Wild bird lays egg at 74
Recalls 300K+ Ram trucks
Massive fire in Baltimore
Romanian election annulled
Promotes trade w/ Mexico
AI bias meter coming
Ethics report release blocked
Sacks to lead AI, crypto
Oven gloves recalled
Scott tapped to lead CBP
Pledges hit $100 billion
Judge rejects plea deal
Hit six months in space
NBA returning to China
White Sox legend dies
Appeals court upholds ban
Blackhawks fire coach
Iran: Space launch successful
Joins X Games as CEO
'Patriot of the Year' award
Syrian rebels advance
Messi wins MLS MVP award
Moon missions delayed
Meet with lawmakers
Feedback